1,152 filings
4
Equels Thomas K.
7 May 24
AIM ImmunoTech / Thomas K Equels ownership change
8:30am
4
Iii Peter W. Rodino
7 May 24
AIM ImmunoTech / Peter W Rodino III ownership change
8:30am
EFFECT
AIM
AIM ImmunoTech Inc
2 May 24
Notice of effectiveness
12:16am
424B5
AIM
AIM ImmunoTech Inc
1 May 24
Prospectus supplement for primary offering
4:35pm
S-1
AIM
AIM ImmunoTech Inc
IPO registration
19 Apr 24
5:01pm
4
x1jz108urx vjfxc
27 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
1:54pm
4
92ce dlwc8sy
27 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
1:52pm
4
o96t53vn87enkqqekv
22 Mar 24
AIM ImmunoTech / NANCY BRYAN ownership change
1:30pm
4
doz7e0460mnb
18 Mar 24
AIM ImmunoTech / STEWART APPELROUTH ownership change
3:01pm
4
le7z2u6j14
18 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
3:01pm
4
3ee9w3i79t
18 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
3:01pm
D/A
b5khqp d5p
21 Feb 24
$3.30 mm in debt, sold $3.30 mm, 1 investor
10:37am
D
pb7y9du
20 Feb 24
Exempt offering of security
4:34pm
8-K
yk8z5kwd4xnkd
20 Feb 24
Entry into a Material Definitive Agreement
4:31pm
8-K
om4i3
9 Feb 24
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
3:47pm
8-K
oqr9v
25 Jan 24
Regulation FD Disclosure
5:00pm
8-K
3o2u43tv
10 Jan 24
Submission of Matters to a Vote of Security Holders
1:42pm
8-K
v32h8n5py9t
10 Jan 24
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating
8:45am
SC 13D/A
0z3sxurt9cn5lxvl
3 Jan 24
AIM ImmunoTech / Deutsch Todd ownership change
4:24pm